Repository logo

Epigenetic regulation in the pathophysiology of Lewy body dementia.

Accepted version

No Thumbnail Available



Change log


Chouliaras, Leonidas  ORCID logo
Kumar, Gautham S 
Thomas, Alan J 
Lunnon, Katie 
Chinnery, Patrick F 


Lewy body dementia encompasses both dementia with Lewy bodies and Parkinson's disease dementia. Although both are common causes of dementia, they remain relatively understudied. The review summarises the clinico-pathologic characteristics of Lewy Body dementia and discusses the genetic and environmental evidence contributing to the risk of developing the condition. Considering that the pathophysiology of Lewy body dementia is not yet fully understood, here we focus on the role of epigenetic mechanisms as potential key mediators of gene-environment interactions in the development of the disease. We examine available important data on genomics, epigenomics, gene expression and proteomic studies in Lewy body dementia on human post-mortem brain and peripheral tissues. Genetic variation and epigenetic modifications in key genes involved in the disorder, such as apolipoprotein E (APOE), α-synuclein (SNCA) and glucocerobrosidase (GBA), suggest a central involvement of epigenetics in DLB but conclusive evidence is scarce. This is due to limitations of existing literature, such as small sample sizes, lack of replication and lack of studies interrogating cell-type specific epigenetic modifications in the brain. Future research in the field can improve the understanding of this common but complex and rapidly progressing type of dementia and potentially open early diagnostic and effective therapeutic targets.



DNA methylation, Dementia with Lewy bodies, Epigenetics, Genetics, Lewy body dementia, Parkinson’s disease dementia, DNA Methylation, Epigenesis, Genetic, Humans, Lewy Body Disease, Parkinson Disease

Journal Title

Prog Neurobiol

Conference Name

Journal ISSN


Volume Title



Elsevier BV